Financhill
Back

Beam Therapeutics Vs. Editas Medicine Industry Stock Comparison

Sell
45

BEAM
Beam Therapeutics

Last Price:
24.83
Seasonality Move:
29.02%
Sell
49

EDIT
Editas Medicine

Last Price:
5.52
Seasonality Move:
18.83%
Sell
45
Beam Therapeutics (BEAM) is a Sell

Is Beam Therapeutics a Buy, Sell or Hold?

  • The current Beam Therapeutics [BEAM] share price is $24.62. The Score for BEAM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $5.62. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BEAM Stock Price Chart

What is Beam Therapeutics's stock price today?

  • The Beam Therapeutics share price today is $24.62
    The current trend is relatively stagnant and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $5.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

BEAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.89 Sell
Relative Strength Index (14 RSI): 50.97 Buy
Chaikin Money Flow: 820935 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.93 - 24.45) Buy
Bollinger Bands (100): (23.39 - 34.29) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 45.45 Sell
Chaikin Money Flow: -1391038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.32 - 5.8) Buy
Bollinger Bands (100): (6.04 - 9.06) Sell

BEAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.3 Buy
20-day SMA: 22.79 Buy
50-day SMA: 27.84 Sell
200-day SMA: 26.69 Sell
8-day EMA: 23.6 Buy
20-day EMA: 23.81 Buy
50-day EMA: 26.24 Sell
200-day EMA: 28.87 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.6 Buy
20-day SMA: 5.52 Buy
50-day SMA: 6.53 Sell
200-day SMA: 8.08 Sell
8-day EMA: 5.68 Sell
20-day EMA: 5.73 Sell
50-day EMA: 6.39 Sell
200-day EMA: 7.99 Sell

Beam Therapeutics Earnings Growth & BEAM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.51 per share, and an increase next year of $0.00 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.41 per share, and an increase next year of $0.04 per share.

Beam Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):